Overview

Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants

Status:
Completed

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the potential effect of naltrexone and bupropion extended-release combination on cardiac repolarization in healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Orexigen Therapeutics, Inc

Treatments:

Bupropion
Bupropion hydrochloride, naltrexone hydrochoride drug combination
Fluoroquinolones
Moxifloxacin
Naltrexone
Norgestimate, ethinyl estradiol drug combination